Table 1.
Safety Population (n = 646) | Efficacy Population (n = 592) | |
Age (yrs) | 34.8 (6 to 83) | 34.7 (6 to 83) |
Gender | 47% M: 53% F | 46% M: 54% F |
Race | 91% Caucasian | 91% Caucasian |
BMI (kg/m2) | 25.5 (0.6) | 25.5 (0.6) |
Height (cm) | 164.2 (14.0) | 164.3 (13.9) |
Weight (kg) | 70.2 (21.6) | 70.1 (21.6) |
Asthmatics (n) | 551 | 505 |
FEV1 (L) | 3.0 (0.9) | 3.0 (0.9) |
% Predicted FEV1 | 95.0 (14.5) | 95.5 (14.7) |
Non-asthmatics (n) | 95 | 91 |
FEV1 (L) | 3.2 (0.9) | 3.2 (0.9) |
% Predicted FEV1 | 94.6 (14.1) | 95.2 (14.4) |